| Bronstein, Gewirtz & Grossman LLC Urges Immutep Limited Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
05/31 |
12:00 |
| Bronstein, Gewirtz & Grossman LLC Urges CommVault Systems, Inc. Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
05/31 |
12:00 |
| Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
05/31 |
12:00 |
| Bronstein, Gewirtz & Grossman LLC Urges Calix, Inc. Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
05/31 |
12:00 |
| Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
05/31 |
12:00 |
| James Altucher Spent Months Researching the Technology Behind the SpaceX IPO. He Put Everything Into One Presentation and Released It for Free |
Globe Newswire |
05/31 |
09:25 |
| Why AI Visibility Operating Systems Are Replacing Fragmented Marketing Strategies |
Globe Newswire |
05/31 |
09:00 |
| Revolution Medicines Announces ASCO Plenary Presentation Highlighting Unprecedented Results from Pivotal Phase 3 RASolute 302 Clinical Trial of Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer |
Globe Newswire |
05/31 |
08:06 |
| Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma |
Globe Newswire |
05/31 |
08:00 |
| SlimTide Truth Revealed (2026 Official Website Risk Warning) Avoid Hidden Fees & Fake Complaints |
Globe Newswire |
05/31 |
06:31 |
| Global Times: Chinese artisan weaves Zhuang brocade into World Cup |
Globe Newswire |
05/30 |
19:45 |
| Global Times: At 80, award winning illustrator Cai Gao still draws inspiration from childhood |
Globe Newswire |
05/30 |
19:44 |
| FLOW Cryptocurrency Investor News: If You Have Suffered Losses in FLOW Cryptocurrency, You Are Encouraged to Contact The Rosen Law Firm About Your Rights |
Globe Newswire |
05/30 |
19:28 |
| Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology |
Globe Newswire |
05/30 |
14:30 |
| Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial |
Globe Newswire |
05/30 |
14:15 |
| ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages POET Technologies Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – POET |
Globe Newswire |
05/30 |
13:41 |
| KIAA International LLC Expands Global Leadership with Senior Corporate General Counsel Ms Jagdeep Kaur Joining as Principal Legal Advisor |
Globe Newswire |
05/30 |
13:20 |
| Global Times: How a novel about ‘qiaopi’ and a filmmaker’s visit led to ‘Dear You’ |
Globe Newswire |
05/30 |
12:33 |
| Global Times: China demonstrates remarkable ability to set a long-term vision and actually execute it |
Globe Newswire |
05/30 |
12:33 |
| Mineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026) |
Globe Newswire |
05/30 |
11:15 |
| SES AI DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages SES AI Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SES |
Globe Newswire |
05/30 |
11:01 |
| NUAI DEADLINE MONDAY: ROSEN, NATIONAL TRIAL LAWYERS, Encourages New Era Energy & Digital, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 1 Deadline in Securities Class Action – NUAI |
Globe Newswire |
05/30 |
10:43 |
| Vapofil Reviews [URGENT REPORT 2026] The Shocking VapoFil Male Enhancement Supplement Trend Everyone Is Talking About |
Globe Newswire |
05/30 |
10:27 |
| ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026 |
Globe Newswire |
05/30 |
10:00 |
| JELLY TIDE [URGENT REPORT 2026]: The Shocking Rise of JellyTide Gummies—What Consumers Need to Know About the Viral Wellness Trend |
Globe Newswire |
05/30 |
09:55 |
